Skip to content
DataLookout
Menu

NCT07904468

Daily Cognitive Failures and Medication Adherence in Fibromyalgia

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Medication Adherence Assessed by MARS-5 in Relation to Pain Severity
Timeframe: Baseline

Secondary (2)

Everyday Cognitive Failures Assessed by the Cognitive Failures Questionnaire (CFQ)
Anxiety Symptoms Assessed by the Hospital Anxiety and Depression Scale (HADS-A)

Arms and interventions

Fibromyalgia Group

Adults aged 18-65 years diagnosed with fibromyalgia according to the 2016 American College of Rheumatology (ACR) criteria and regularly taking at least one medication for fibromyalgia. Participants will undergo a single-visit assessment using the Cognitive Failures Questionnaire (CFQ), Medication Adherence Report Scale (MARS-5), and Hospital Anxiety and Depression Scale (HADS). Demographic characteristics, pain severity, and medication use will also be recorded. No experimental interventions or additional medical procedures will be performed.

Sites

1 site in 1 country

  • Mardin Training and Research HospitalMardin, Turkey (Türkiye)